Doug Schenkel
Stock Analyst at Wolfe Research
(3.57)
# 881
Out of 4,712 analysts
67
Total ratings
51.02%
Success rate
31.45%
Average return
Main Sectors:
Stocks Rated by Doug Schenkel
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| TEM Tempus AI | Initiates: Outperform | $60 | $35.12 | +70.84% | 1 | Dec 13, 2024 | |
| HOLX Hologic | Initiates: Peer Perform | n/a | $72.60 | - | 5 | Dec 13, 2024 | |
| TWST Twist Bioscience | Initiates: Outperform | $60 | $48.17 | +24.57% | 2 | Dec 13, 2024 | |
| STVN Stevanato Group | Initiates: Outperform | $28 | $21.61 | +29.57% | 1 | Dec 13, 2024 | |
| WST West Pharmaceutical Services | Initiates: Peer Perform | n/a | $333.22 | - | 1 | Dec 13, 2024 | |
| RGEN Repligen | Initiates: Peer Perform | n/a | $145.54 | - | 1 | Nov 14, 2024 | |
| MRVI Maravai LifeSciences Holdings | Initiates: Peer Perform | n/a | $5.50 | - | 1 | Nov 14, 2024 | |
| DHR Danaher | Upgrades: Outperform | $285 | $231.10 | +23.32% | 2 | Oct 31, 2024 | |
| BRKR Bruker | Downgrades: Peer Perform | n/a | $58.41 | - | 2 | Sep 30, 2024 | |
| A Agilent Technologies | Downgrades: Peer Perform | n/a | $135.54 | - | 8 | Jun 27, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Outperform | $50 | $44.99 | +11.14% | 2 | Jun 27, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Peer Perform | n/a | $14.59 | - | 3 | Jun 27, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | n/a | $135.27 | - | 5 | Dec 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | n/a | $57.55 | - | 4 | Dec 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | n/a | $526.07 | - | 3 | Dec 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | n/a | $13.42 | - | 1 | Dec 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Peer Perform | n/a | $111.99 | - | 1 | Dec 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Peer Perform | n/a | $1.86 | - | 1 | Dec 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Peer Perform | n/a | $21.41 | - | 1 | Dec 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Peer Perform | n/a | $30.44 | - | 2 | Dec 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | n/a | $160.26 | - | 3 | Dec 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Peer Perform | n/a | $374.60 | - | 1 | Dec 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | n/a | $3.36 | - | 1 | Aug 17, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Market Perform | n/a | $2.77 | - | 1 | Aug 16, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | n/a | $8.00 | - | 1 | Aug 9, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | n/a | $19.60 | - | 1 | Jun 21, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | n/a | $2.26 | - | 1 | Jan 12, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | n/a | $2.26 | - | 1 | Dec 29, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | n/a | $7.14 | - | 1 | Jul 7, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $18 | $4.99 | +260.72% | 1 | Jun 19, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Outperform | n/a | $36.88 | - | 2 | Mar 28, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $80 → $90 | $265.12 | -66.05% | 2 | Feb 22, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | n/a | $11.06 | - | 1 | Jan 2, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | n/a | $187.90 | - | 1 | Nov 1, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $23 → $16 | $80.24 | -80.06% | 2 | Sep 28, 2017 |
Tempus AI
Dec 13, 2024
Initiates: Outperform
Price Target: $60
Current: $35.12
Upside: +70.84%
Hologic
Dec 13, 2024
Initiates: Peer Perform
Price Target: n/a
Current: $72.60
Upside: -
Twist Bioscience
Dec 13, 2024
Initiates: Outperform
Price Target: $60
Current: $48.17
Upside: +24.57%
Stevanato Group
Dec 13, 2024
Initiates: Outperform
Price Target: $28
Current: $21.61
Upside: +29.57%
West Pharmaceutical Services
Dec 13, 2024
Initiates: Peer Perform
Price Target: n/a
Current: $333.22
Upside: -
Repligen
Nov 14, 2024
Initiates: Peer Perform
Price Target: n/a
Current: $145.54
Upside: -
Maravai LifeSciences Holdings
Nov 14, 2024
Initiates: Peer Perform
Price Target: n/a
Current: $5.50
Upside: -
Danaher
Oct 31, 2024
Upgrades: Outperform
Price Target: $285
Current: $231.10
Upside: +23.32%
Bruker
Sep 30, 2024
Downgrades: Peer Perform
Price Target: n/a
Current: $58.41
Upside: -
Agilent Technologies
Jun 27, 2024
Downgrades: Peer Perform
Price Target: n/a
Current: $135.54
Upside: -
Jun 27, 2024
Upgrades: Outperform
Price Target: $50
Current: $44.99
Upside: +11.14%
Jun 27, 2024
Downgrades: Peer Perform
Price Target: n/a
Current: $14.59
Upside: -
Dec 13, 2023
Initiates: Outperform
Price Target: n/a
Current: $135.27
Upside: -
Dec 13, 2023
Initiates: Outperform
Price Target: n/a
Current: $57.55
Upside: -
Dec 13, 2023
Initiates: Outperform
Price Target: n/a
Current: $526.07
Upside: -
Dec 13, 2023
Initiates: Outperform
Price Target: n/a
Current: $13.42
Upside: -
Dec 13, 2023
Initiates: Peer Perform
Price Target: n/a
Current: $111.99
Upside: -
Dec 13, 2023
Initiates: Peer Perform
Price Target: n/a
Current: $1.86
Upside: -
Dec 13, 2023
Initiates: Peer Perform
Price Target: n/a
Current: $21.41
Upside: -
Dec 13, 2023
Initiates: Peer Perform
Price Target: n/a
Current: $30.44
Upside: -
Dec 13, 2023
Initiates: Outperform
Price Target: n/a
Current: $160.26
Upside: -
Dec 13, 2023
Initiates: Peer Perform
Price Target: n/a
Current: $374.60
Upside: -
Aug 17, 2021
Initiates: Outperform
Price Target: n/a
Current: $3.36
Upside: -
Aug 16, 2021
Initiates: Market Perform
Price Target: n/a
Current: $2.77
Upside: -
Aug 9, 2021
Initiates: Outperform
Price Target: n/a
Current: $8.00
Upside: -
Jun 21, 2021
Initiates: Outperform
Price Target: n/a
Current: $19.60
Upside: -
Jan 12, 2021
Initiates: Outperform
Price Target: n/a
Current: $2.26
Upside: -
Dec 29, 2020
Initiates: Outperform
Price Target: n/a
Current: $2.26
Upside: -
Jul 7, 2020
Initiates: Outperform
Price Target: n/a
Current: $7.14
Upside: -
Jun 19, 2018
Initiates: Outperform
Price Target: $18
Current: $4.99
Upside: +260.72%
Mar 28, 2018
Upgrades: Outperform
Price Target: n/a
Current: $36.88
Upside: -
Feb 22, 2018
Maintains: Outperform
Price Target: $80 → $90
Current: $265.12
Upside: -66.05%
Jan 2, 2018
Initiates: Outperform
Price Target: n/a
Current: $11.06
Upside: -
Nov 1, 2017
Downgrades: Market Perform
Price Target: n/a
Current: $187.90
Upside: -
Sep 28, 2017
Maintains: Outperform
Price Target: $23 → $16
Current: $80.24
Upside: -80.06%